Issue Title
Vol 22, No 1 (2020) Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
Abstract PDF
(Rus)
Kolyadina I.V., Danzanova T.Y., Khokhlova S.V., Trofimova O.P., Kovaleva E.V., Rodionov V.V., Poddubnaya I.V.
Vol 17, No 1 (2015) A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian
Abstract
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
Vol 22, No 1 (2020) The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study
Abstract PDF
(Rus)
Kovalenko E.I., Artamonova E.V., Karabina E.V., Andreiashkina I.I., Prokof’eva E.A., Popova N.O., Gaisina E.A., Evstigneeva I.V., Shaidorov M.V., Zhiliaeva L.A., Ponomarenko D.M., Khasanova A.I., Mukhametshina G.Z., Koziakov A.E., Vorotilina L.V., Povyshev A.I., Simolina E.I., Marfutov V.V., Kozlov D.V., Suslova I.R., Shikina V.E., Karandeeva T.V., Shepel’ A.O., Kramskaia L.V., Oskirko D.A., Frolova O.S.
Vol 16, No 3 (2014) Avastin in clinical chemotherapy of malignant tumors
Abstract
Gorbunova V.A.
Vol 15, No 3 (2013) Prognosticheskoe znachenie lokal'nogo i sistemnogo lecheniya pri rake molochnoy zhelezy I stadii
Abstract
Kolyadina I.V., Poddubnaya I.V., Trofimova O.P., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V., Frank G.A., Banov S.M.
Vol 17, No 1 (2015) Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience)
Abstract
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Frank G.A., Komov D.V., Karseladze A.I., Bastiaannet E., Dekker-Ensink N.G.
Vol 20, No 2 (2018) The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Abstract PDF
(Rus)
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
Vol 18, No 2 (2016) Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Abstract PDF
(Rus)
Karabina E.V., Zhukova L.G.
Vol 19, No 1 (2017) Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
Abstract PDF
(Rus)
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
Vol 15, No 2 (2013) Prognostic value of p53 expression in patients with stage I breast cancer
Abstract
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Liefers G.J., Dekker-Ensink N.G., Bastiaannet E., Van As-Sajet A., Prinse B., Engels C., Van Vlierberghe R., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V., Frank G.A., Banov S.M.
Vol 20, No 3 (2018) The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Abstract PDF
(Rus)
Kolyadina I.V., Poddubnaya I.V.
Vol 21, No 3 (2019) The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
Abstract PDF
(Rus)
Gordeeva O.O., Kolyadina I.V., Zhukova L.G., Gan'shina I.P., Komov D.V., Meshcheriakov A.A.
Vol 18, No 1 (2016) Rare morphological forms of breast cancer: features of surgical approach
Abstract PDF
(Rus)
Vysotskaya I.V., Letyagin V.P., Kolyadina I.V., Martynova G.V.
Vol 11, No 4 (2009) Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
Abstract
Lichinitser M.R., Semenov N.N.
Vol 17, No 1 (2015) The use of combined plastic interventions in the reconstruction of post-operative soft tissue defects of the chest wall in the surgical treatment of locally advanced breast cancer
Abstract
Vashenko L.N., Daschkova I.R., Bakulina S.M., Andreyko E.A.
Vol 21, No 1 (2019) The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
Abstract PDF
(Rus)
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I.
Vol 19, No 2 (2017) PARP inhibitors in female reproductive system cancers
Abstract PDF
(Rus)
Pokataev I.A., Tyulyandin S.A.
Vol 8, No 1 (2006) Keliks (pegilirovannyy liposomal'nyy doksorubitsin) v programmnoy terapii 2-y linii metastaticheskogo raka molochnoy zhelezy
Abstract
Vol 20, No 2 (2018) The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)
Abstract PDF
(Rus)
Stepanova A.M., Merzlyakova A.M., Khulamhanova M.M., Trofimova O.P.
Vol 9, No 3 (2007) Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie
Abstract
Komarova V.P., Komarova L.E., Poddubnaya I.V.
Vol 19, No 3 (2017) Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer
Abstract PDF
(Rus)
Nenakhova Y.N., Lyadov V.K., Poddubnaya I.V.
Vol 17, No 4 (2015) Neoadjuvant systemic therapy of HER2-positive breast cancer
Abstract
Frolova M.A.
Vol 16, No 3 (2014) Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial
Abstract
Ahmetzanov F.S., Ahmetzanova F.F.
Vol 11, No 1 (2009) Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin
Abstract
Borisova E.I., Voronina I.Y., Gutorov S.L.
Vol 18, No 3 (2016) The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015
Abstract PDF
(Rus)
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
Vol 8, No 1 (2006) Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy
Abstract
Samoylenko V.M., Gorbunova V.A., Koshelev M.N., Yurashko K.V.
Vol 7, No 1 (2005) Faktory prognoza pri rake molochnoy zhelezy
Abstract
Bozhok A.A., Semiglazov V.F., Semiglazov V.V., Arzumanov A.S., Kletsel' A.E.
Vol 16, No 4 (2014) Male breast cancer: review of the literature
Abstract
Nikolaev K.S., Semiglazov V.F., Semiglazov V.V.
Vol 9, No 3 (2007) Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
Abstract
Myasnikova M.O.
Vol 19, No 4 (2017) Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case
Abstract PDF
(Rus)
Kolyadina I.V., Ganshina I.P., Zhukova L.G., Abdullaev A.G., Andreeva Y.Y., Danzanova T.Y., Sinyukova G.T., Komov D.V., Kozlov N.A., Filonenko D.A., Gordeeva O.O., Lubennikova E.V.
Vol 9, No 1 (2007) Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy?
Abstract
Ptushkin V.V.
Vol 7, No 2 (2005) Farmorubitsin v klinicheskoy praktike
Abstract
Gorbunova V.A.
Vol 11, No 4 (2009) Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy
Abstract
Artamonova E.V.
Vol 20, No 2 (2018) Ribociclib in 1st line HR+ breast cancer treatment
Abstract PDF
(Rus)
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V.
Vol 9, No 2 (2007) Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Abstract
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Vol 7, No 3 (2005) Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005)
Abstract
Letyagin V.P., Vysotskaya I.V.
Vol 21, No 1 (2019) Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports
Abstract PDF
(Rus)
Savelyeva M.I., Dudina I.A., Zaharenkova J.S., Ignatova A.K., Ryzhikova K.A., Sozaeva Z.A., Kudlay D.A., Perfileva O.M., Poddubnaya I.V.
Vol 17, No 2 (2015) Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Abstract
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A.
Vol 11, No 1 (2009) Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
Abstract
Zhukova L.G.
Vol 9, No 1 (2007) Immunogistokhimicheskoe opredelenie ekspressii HER2/neu pri rake molochnoy zhelezy (po dannym Smolenskogo oblastnogo onkologicheskogo klinicheskogo dispansera)
Abstract
Shisterova O.A., Golik E.P.
Vol 7, No 2 (2005) Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy
Abstract
Makarenko N.P.
Vol 19, No 2 (2017) Perspectives of pharmacogenetics approach to personalized tamoxifen therapy
Abstract PDF
(Rus)
Savelyeva M.I., Ignatova A.K., Panchenko Y.S., Urvantseva I.A., Poddubnaya I.V.
Vol 18, No 2 (2016) New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Abstract PDF
(Rus)
Semiglazova T.Y., Klyuge V.A., Semiglazov V.V., Teletaeva G.M., Krivorotko P.V., Dashyan G.A., Paltuev R.M., Tkachenko E.V., Donskikh R.V., Semiglazov V.F.
Vol 11, No 4 (2009) Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
Abstract
Vol 20, No 2 (2018) Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Abstract PDF
(Rus)
Frolova M.A., Kochetkova Y.I., Chubenko V.A., Volkov N.M., Moiseenko F.V., Garmarnik T.V., Ponomarenko D.M., Orlov A.E., Kostalanova Y.V., Makarycheva Y.Y., Nizegorodzeva A.A.
Vol 19, No 1 (2017) Albumin-bound paclitaxel in the treatment of metastatic breast cancer
Abstract PDF
(Rus)
Artamonova E.V.
Vol 9, No 3 (2007) Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy
Abstract
Khvastunov R.A., Kireev A.V., Nikol'skiy I.V., Suvorov V.A.
Vol 17, No 2 (2015) Stereotactic biopsy of breast lesions under x-ray control
Abstract
Manikhas G.M., Safronova O.B., Khudjakova T.G., Barabanova L.P., Punanova N.J.
Vol 16, No 3 (2014) Personalized approach to HER2-positive advanced breast cancertherapy
Abstract
Stenina M.B.
Vol 8, No 4 (2006) Vliyanie rekonstruktivno-plasticheskikh operatsiy na kachestvo zhizni bol'nykh rakom molochnoy zhelezy v otdalennom periode
Abstract
Arslanov K.S., Tkachenko G.A.
Vol 19, No 2 (2017) Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary?
Abstract PDF
(Rus)
Trigolosov A.V., Uimanov V.A., Chernikh M.V., Petrovskiy A.V., Nikitina E.A., Nechushkin M.I.
Vol 17, No 1 (2015) Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Abstract
Semiglazova T.Y., Dashyan G.A., Semiglazov V.V., Zhabina A.S., Osipov M.A., Kotova Z.S., Klimenko V.V., Krivorotko P.V., Semiglazov V.F.
Vol 20, No 2 (2018) Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?
Abstract PDF
(Rus)
Zhukova L.G., Ganshina I.P., Khatkova E.I., Tikhomirova T.E., Kondratyeva O.E.
Vol 16, No 4 (2014) Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I?
Abstract
Kolyadina I.V., Poddubnaya I.V., Trofimova O.P., Frank G.A., Karseladze A.I., Komov D.V.
Vol 15, No 4 (2013) The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Abstract
Semiglazov V.F., Semiglazov V.V., Paltuev P.M., Nikolaev K.S., Dashyan G.A.
Vol 9, No 2 (2007) Primenenie Zomety na fone endokrinnoy terapii Femaroy u bol'nykh rakom molochnoy zhelezy s metastazami v kosti
Abstract
Konstantinova M.M., Ovchinnikova L.K., Lomakin N.N., Galleev M.G., Neretina E.S., Mukhamedshina G.Z., Mukhametgaleeva F.K.
Vol 7, No 3 (2005) Aromazin: printsip deystviya
Abstract
Imyanitov E.N.
Vol 21, No 1 (2019) Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
Abstract PDF
(Rus)
Gorbunova V.A., Kolyadina I.V., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Filonenko D.V., Zhilyaeva L.A., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Suslova I.R., Romanchuk O.V., Kozlov D.V., Rzaev A.S., Marfutov V.V., Andreiashkina I.I., Vladimirova L.I., Mitashok I.S., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Morozov D.A., Prokof'eva E.P., Kramskaia L.V., Karandeeva T.V., Evstigneeva I.V., Ovchinnikova E.G., Klement'eva T.P., Khrupalo O.V., Tiuvinova E.V., Sherstnev V.M., Chernov I.S., Kolokolov D.D., Gaisina E.A., Levchenko N.V., Chubenko V.A., Povyshev A.I., Iudina I.V., Vorotilina L.V., Andreeva T.V., Tumanian G.S., Koziakov A.E., Gil'mutdinova L.A., Osipov M.A., Shatokhina A.S., Vazhenina A.A., Chichkanova A.S., Vladimirov V.I., Ivanov A.N., Belokhvostova A.S., Cherniakova E.M., Tul'china E.A., Maklashova S.A., Shkodenko O.N., Kostalanova I.V., Tarasova A.V., Kuz'mina E.S.
Vol 19, No 4 (2017) Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0
Abstract PDF
(Rus)
Pavlikova O.A., Poddubnaya I.V., Kolyadina I.V., Abdullaev A.G., Komov D.V., Danzanova T.Y., Sinyukova G.T., Kozlov N.A., Ganshina I.P., Zhukova L.G., Aliyeva G.S., Kerimov R.A., Gordeeva O.O.
Vol 18, No 4 (2016) Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer
Abstract
Vladimirova L.Y.
Vol 17, No 2 (2015) Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy
Abstract
Artamonova E.V., Manziuk L.V.
Vol 16, No 2 (2014) High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)
Abstract
Seryakov A.P., Ovchinnikova L.K., Zabelin M.V., Yakubov T.Z., Sidorov D.B., Ovchinnikov M.V.
Vol 15, No 2 (2013) New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
Abstract
Artamonova E.V., Manzyuk L.V.
Vol 7, No 2 (2005) Biologicheskie kharakteristiki opukholi (proliferativnaya aktivnost', ploidnost' i steroidnye retseptory) i ikh vliyanie na neposredstvennye i otdalennye rezul'taty lecheniya zapushchennogo raka molochnoy zhelezy
Abstract
Nikolaeva T.G., Vyshinskaya G.V., Rotobel'skaya L.E.
Vol 10, No 1 (2008) Effektivnost' ad\"yuvantnoy terapii anastrozolom i tamoksifenom u patsientok s rannimi stadiyami raka molochnoy zhelezy (analiz dannykh issledovaniya ATAC pri mediane vremeni nablyudeniya 100 mes)
Abstract
Vol 20, No 1 (2018) Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
Abstract PDF
(Rus)
Kolbin A.S., Mosikyan A.A., Balykina Y.E., Proskurin M.A.
Vol 15, No 3 (2013) Rezul'taty «Epidemiologicheskoy programmy skrininga HER2-statusa u bol'nykh rakom molochnoy zhelezy» v Rossiyskoy Federatsii
Abstract
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A.
Vol 21, No 2 (2019) The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
Abstract PDF
(Rus)
Kolyadina I.V., Bulavina I.S., Petkau V.V., Strakhova N.V., Gorbunova V.A., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Gan'shina I.P., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Khokhlova S.V., Filonenko D.V., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Vladimirova L.I., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Orlov A.E., Kostalanova I.V., Levchenko N.V., Osipov M.A., Karandeeva T.V., Evstigneeva I.V., Chernov I.S., Kolokolov D.D., Povyshev A.I., Shatokhina A.S., Cherniakova E.M., Shkodenko O.N., Kuz'mina E.S.
Vol 17, No 2 (2015) The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients
Abstract
Frank G.A., Ilatovskaia M.E., Andreeva I.I., Zavalishina L.E.
Vol 16, No 3 (2014) Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women
Abstract
Jackisch C., Llombart-Cussac A.
Vol 16, No 1 (2014) New chemotherapy options for triple-negative breast cancer (review of literature)
Abstract
Sekundova M.A., Zdvizhkov A.M., Borisov V.I.
Vol 18, No 3 (2016) Circulating tumor cell: biology, methods of isolation, clinical significance in breast cancer
Abstract PDF
(Rus)
Nenahova Y.N., Lyadov V.K., Poddubnaya I.V.
Vol 11, No 2 (2009) Kachestvo zhizni i simptomyu bol'nykh disseminirovannym gormonopozitivnym rakom molochnoy zhelezy v postmenopauze na fone primeneniya Fazlodeksa
Abstract
Novik A.A., Ionova T.I., Kalyadina S.A.
Vol 9, No 3 (2007) Femara (letrozol) v ad\"yuvantnoy terapii raka molochnoy zhelezy
Abstract
Stenina M.B.
Vol 16, No 2 (2014) The results of Epidemiological HER2 screening program in patients with breast cancer in 2013
Abstract
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A., Koroleva N.I.
Vol 11, No 3 (2009) Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
Abstract
Zhukova L.G., Abramov M.E., Vakhabova Y.V., Lud A.N., Obukhov A.A., Lichinitser M.R.
Vol 10, No 1 (2008) Tayverb/Tyverb (lapatinib) – pervyy dvoynoy anti-ErbB1(EGFR)i anti-ErbB2(HER2)-ingibitor v lechenii mestno-rasprostranennogo i metastaticheskogo raka molochnoy zhelezy zaregistrirovan v Rossiyskoy Federatsii
Abstract
Vol 21, No 3 (2019) Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population
Abstract PDF
(Rus)
Grechukhina K.S., Zhukova L.G.
Vol 11, No 2 (2009) HER-2-targetnaya terapiya raka molochnoy zhelezy: monoklonal'nye antitela i ingibitory tirozinkinazy
Abstract
Ognerubova I.N.
Vol 9, No 2 (2007) Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Abstract
Semiglazov V.F., Semiglazov V.V.
Vol 18, No 2 (2016) Cost-effectiveness of empegfilgrastim (Extimia®) for the prevention of severe neutropenia in patients with malignant neoplasm of female breast
Abstract PDF
(Rus)
Rudakova A.V., Tolkacheva D.G., Gavrilova O.N., Vaganov A.S.
Vol 16, No 2 (2014) Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Abstract
Artamonova E.V., Gorbunova V.A., Zhukov N.V., Manzjuk L.V., Manihas A.G., Paltuev P.M., Semiglazov V.F., Semiglazova T.Y., Stenina M.B., Tjuljandin S.A., Chubenko V.A.
Vol 7, No 2 (2005) «Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy»
Abstract
Semiglazov V.F., Poddubnaya I.V.
Vol 11, No 3 (2009) Klinicheskiy sluchay effektivnogo lecheniya lapatinibom (Tayverb)i kapetsitabinom (Kseloda) bol'noy disseminirovannym rakom molochnoy zhelezy s giperekspressiey ErbB2 (Her-2/neu) s metastaticheskim porazheniem veshchestva i obolochek golovnogo mozga
Abstract
Naskhletashvili D.R., Chmutin G.E.
Vol 10, No 1 (2008) 8 let nadezhdy: novye dannye issledovaniya ATAS
Abstract
Vol 20, No 1 (2018) Dermatomyositis and polymyositis in breast cancer patients: a case reports
Abstract PDF
(Rus)
Ganshina I.P., Zhukova L.G., Burnevitch E.Z., Gordeeva O.O., Kondratieva O.E.
Vol 17, No 3 (2015) The results of Epidemiological HER2 screening program in patients with breast cancer in 2014
Abstract
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
Vol 11, No 2 (2009) Rol' Taksotera v lechenii metastaticheskogo raka molochnoy zhelezy
Abstract
Kolyadina I.V., Makarenko N.P., Poddubnaya I.V.
Vol 19, No 3 (2017) Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Abstract PDF
(Rus)
Artamonova E.V.
Vol 18, No 3 (2016) The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer
Abstract PDF
(Rus)
Frolova M.A.
Vol 7, No 1 (2005) Opyt primeneniya Regional'noy programmy v g. Krasnodare
Abstract
Mitashok I.S.
Vol 15, No 4 (2013) Bone mineral density in patient with breast cancer
Abstract
Poddubnaya I.V., Kizhaev E.V., Kolyadina I.V., Banov S.M., Zhmaeva E.M., Secko M.A.
Vol 11, No 3 (2009) Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Abstract
Semiglazov V.F., Semiglazov V.V., Zhil'tsova E.K.
Vol 11, No 2 (2009) Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Abstract
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Vol 9, No 2 (2007) Sovremennaya taktika ad\"yuvantnoy lekarstvennoy terapii bol'nykh operabel'nym (rannim) rakom molochnoy zhelezy
Abstract
Perevodchikova N.I.
Vol 18, No 2 (2016) Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study
Abstract PDF
(Rus)
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
Vol 17, No 1 (2015) Radiation-induced lung injury in breast cancer patients after breast conservation therapy
Abstract
Trofimova O.P., Tkachev S.I., Ivanov S.M., Utkina V.L., Cheban O.I., Glebovskaya V.V.
Vol 16, No 2 (2014) Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards
Abstract
Vol 15, No 1 (2013) Current approach to adjuvant therapy for breast cancer (a review)
Abstract
Conte P., Guarneri V.
Vol 7, No 1 (2005) Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere
Abstract
Chevardov N.I., Tolstykh L.V., Puzakov K.G., Potapov Y.N.
1 - 100 of 106 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies